Plasma protein changes induced by two orally administered androgen derivatives

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 2, 1996, Pages 161-166

  Rannevik, G ^a,c   Carlstrom K ^b   Doeberl, A ^c   Laurell, C B ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Fertility Research Institute   (Sweden)

Author keywords

androgenic activity; danazol; epostane; plasma proteins; sex hormone binding globulin

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; DANAZOL; EPOSTANE; HIGH DENSITY LIPOPROTEIN; PLASMA PROTEIN; PREALBUMIN; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; SEX HORMONE BINDING GLOBULIN; THYROXINE BINDING GLOBULIN; TRANSCORTIN; TRANSFERRIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ASTEROIDEA;

EID: 0029930344     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609088603     Document Type: Article

References (26)

1. Laurell C-B, Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy and estrogens. J Clin Endocrinol Metab 1979; 49: 719-25.
2. Damber MG, Sandström B, von Schoultz B, Stigbrand T. A new sensitive method for quantifying and comparing the biological potency of various estrogens in man. Acta Obstet Gynecol Scand 1979; 58: 527-30.
3. Von Schoultz B, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette Å, et al. Estrogen therapy and liver function. Metabolic effects of oral and parenteral administration. The Prostate 1989; 14: 389-95.
4. Rannevik G, Thorell JI. The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women. Acta Obstet Gynecol Scand 1984; Suppl 123: 89-94.
5. Dickey RP, Taylor SN, Curole DN. Serum estradiol and danazol. 1. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone. Fertil Steril 1986; 42: 709-16.
6. Steingold KA, Lu JKH, Judd HL, Meldrum DR. Danazol inhibits steroidogenesis by the human ovary. Fertil Steril 1986; 45: 649-54.
7. Barbieri RL, Canick JA, Makris A, Todd RB, Davies IJ, Ryan KJ. Danazol inhibits steroidogenesis. Fertil Steril 1977; 28: 809-13.
8. Potts GO. Pharmacology of danazol. J Int Med Res 1977; Suppl 3: 1-14.
9. Rabe T, Kiesel L, Kellermann J, Weidenhammer K, Runnebaum B, Potts GO. Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitors in vitro. Fertil Steril 1983; 39: 829-35.
10. Creange JE, Anzalone AJ, Potts GO, Schane HP. WIN 32729. A new potent interceptive agent in rats and rhesus monkeys. Contraception 1981; 24: 289-99.
11. Christiansen RG, Neumann HC, Salvador UJ, Bell MR, Schane HP, Creange JE, et al. Steroidogenesis inhibitors. I. Adrenal inhibitory and interceptive activity of trilostane and related compounds. J Med Chem 1984; 27: 928-31.
12. Snyder BW, Beecham GD, Schane HP. Inhibition of ovulation in rats with epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase. Proc Soc Exp Biol Med 1984; 176: 238-42.
13. Snyder BW, Schane HP. Inhibition of luteal phase progesterone levels in the rhesus monkey by epostane. Contraception 1985; 31: 479-86.
14. Sterling-Winthrop Research Institute, A summary of laboratory data on WIN 327 29. Rensselaer, New York: Sterling-Winthrop Research Institute, 1981.
15. Slotman BJ, Rao BR. Response to inhibition of androgen action of human ovarian cancer cells in vitro. Cancer 1989; 45: 213-20.
16. Rannevik G, Doeberl A, Valentin L. Epostane in non-pregnant females: effects on progesterone, 17α-hydroxyprogesterone and estradiol-17β of two dose levels given for one month. Fertil Steril 1988; 50: 893-902.
17. Van Look P, Bygdeman M. Antiprogestational steroids: a new dimension in human fertility regulation. Oxford Rev Reprod Biol 1989; 11: 1-60.
18. Birgerson L, Odlind V, Johansson EDB. Effects of epostane on progesterone synthesis in early human pregnancy. Contraception 1986; 33: 401-10.
19. Birgerson L, Ölund A, Odlind V, Somell C. Termination of early pregnancy with epostane. Contraception 1987; 35: 111-20.
20. Mainwaring MIP. Steroid hormone receptors: a survey. Vitamines Hormones 1975; 33: 223-45.
21. Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; Suppl 124: 21-37.
22. Fernlund P, Gershagen S, Larsson I, Rannevik G. Radioimmunoassay of human sex hormone binding globulin: improved radioiodination procedure. Scand J Clin Lab Invest 1985; 45: 461-69.
23. Gershagen S, Doeberl A, Rannevik G. Changes in the SHBG concentration during danazol treatment. Acta Obstet Gynecol Scand 1984; Suppl 123: 117-23.
24. Von Schoultz B, Carlström K. On the regulation of sex hormone-binding globulin - a challenge of an old dogma and outlines of a new hypothesis. J Steroid Biochem 1989; 32: 327-34.
25. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995; 21: 103-13.
26. Gershagen S, Doeberl A, Jeppsson S, Rannevik G. Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study. Fertil Steril 1989; 51: 616-21.